Ochre Bio logo

Ochre Bio

Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.

4

Funding Rounds

$49.4m

Money raised

Overview

Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.

Funding

Funding series

Funding Series Analysis

The company Ochre Bio has raised a total of $49.35m in funding over 4 rounds.

Key Insights:

  • Ochre Bio October 2022 Series A Funding Round: $30m
  • Ochre Bio Seed round, June 2021: $9.6m
  • Ochre Bio June 2021 Seed Funding Round: $9.6m
  • Ochre Bio March 2020 Pre-Seed Funding Round: $150k
Ochre Bio logo
Ochre Bio October 2022 Series A Funding Round $30m
Ochre Bio logo
Ochre Bio Seed round, June 2021 $9.6m
Ochre Bio logo
Ochre Bio June 2021 Seed Funding Round $9.6m
Ochre Bio logo
Ochre Bio March 2020 Pre-Seed Funding Round $150k